Targeting Epigenetics in Cancer
- PMID: 28992434
- PMCID: PMC5800772
- DOI: 10.1146/annurev-pharmtox-010716-105106
Targeting Epigenetics in Cancer
Abstract
Alterations of genes regulating epigenetic processes are frequently found as cancer drivers and may cause widespread alterations of DNA methylation, histone modification patterns, or chromatin structure that disrupt normal patterns of gene expression. Because of the inherent reversibility of epigenetic changes, inhibitors targeting these processes are promising anticancer strategies. Small molecules targeting epigenetic regulators have been developed recently, and clinical trials of these agents are under way for hematologic malignancies and solid tumors. In this review, we describe how the writers, readers, and erasers of epigenetic marks are dysregulated in cancer and summarize the development of therapies targeting these mechanisms.
Keywords: DNA methylation; anticancer therapies; epigenetic readers; epigenetics; histone acetylation; histone methylation.
References
-
- Kornberg RD. Chromatin structure: a repeating unit of histones and DNA. Science. 1974;184:868–71. - PubMed
-
- Richmond TJ, Finch JT, Rushton B, Rhodes D, Klug A. Structure of the nucleosome core particle at 7 A resolution. Nature. 1984;311:532–7. - PubMed
-
- Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 1997;389:251–60. - PubMed
-
- Brownell JE, Zhou J, Ranalli T, Kobayashi R, Edmondson DG, et al. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell. 1996;84:843–51. - PubMed
-
- Luger K, Richmond TJ. The histone tails of the nucleosome. Current opinion in genetics & development. 1998;8:140–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources